MedPath

LMC Diabetes & Endocrinology Ltd.

LMC Diabetes & Endocrinology Ltd. logo
🇨🇦Canada
Ownership
Holding
Established
1997-01-01
Employees
51
Market Cap
-
Website
http://www.lmc.ca

Real-world Effect of Switching From Intermittently-scanned to Real-time Continuous Glucose Monitoring (Switch CGM Retro)

Completed
Conditions
Diabetes Mellitus
First Posted Date
2025-05-08
Last Posted Date
2025-05-11
Lead Sponsor
LMC Diabetes & Endocrinology Ltd.
Target Recruit Count
220
Registration Number
NCT06962735
Locations
🇨🇦

LMC Diabetes & Endocrinology Ltd., Toronto, Ontario, Canada

Real-world Effects of Using Intermittently Scanned Continuous Glucose Monitoring and Pharmacist-led Coaching on the Management of Type 2 Diabetes Among Adults Not Using Insulin (REAL isCGM T2D)

Recruiting
Conditions
Type 2 Diabetes
First Posted Date
2025-02-20
Last Posted Date
2025-05-04
Lead Sponsor
LMC Diabetes & Endocrinology Ltd.
Target Recruit Count
250
Registration Number
NCT06837103
Locations
🇨🇦

LMC Diabetes & Endocrinology Ltd., Toronto, Ontario, Canada

Effect of Switching From Intermittently Scanned to Real-time Continuous Glucose Monitoring on Diabetes Management in Adults With Type 2 Diabetes (Switch CGM T2D)

Recruiting
Conditions
Type 2 Diabetes
First Posted Date
2025-02-03
Last Posted Date
2025-05-04
Lead Sponsor
LMC Diabetes & Endocrinology Ltd.
Target Recruit Count
150
Registration Number
NCT06805786
Locations
🇨🇦

LMC Diabetes & Endocrinology Ltd., Toronto, Ontario, Canada

Impact of GLP-1 RAs Compared to Basal Insulin Start in Patients Living With Type 2 Diabetes and Chronic Kidney Disease

Completed
Conditions
Type 2 Diabetes
Chronic Kidney Diseases
Interventions
Drug: GLP-1 receptor agonist
First Posted Date
2024-02-01
Last Posted Date
2024-02-01
Lead Sponsor
LMC Diabetes & Endocrinology Ltd.
Target Recruit Count
348
Registration Number
NCT06236672
Locations
🇨🇦

LMC Diabetes & Endocrinology Ltd., Toronto, Ontario, Canada

The Canadian Diabetes Prevention Program

Not Applicable
Active, not recruiting
Conditions
Diabetes type2
Interventions
Behavioral: DPP Curriculum for Lifestyle Intervention
First Posted Date
2023-03-24
Last Posted Date
2023-03-24
Lead Sponsor
LMC Diabetes & Endocrinology Ltd.
Target Recruit Count
2174
Registration Number
NCT05784220
Locations
🇨🇦

LMC Diabetes Ltd, Toronto, Ontario, Canada

Clinical Outcomes From Enhanced SCREENing Strategies for NASH in Type 2 Diabetes (SCREEN NASH T2D)

Not Applicable
Recruiting
Conditions
Nonalcoholic Steatohepatitis
Type 2 Diabetes
Interventions
Other: routine screening
Other: physician-driven screening
First Posted Date
2021-08-31
Last Posted Date
2024-01-24
Lead Sponsor
LMC Diabetes & Endocrinology Ltd.
Target Recruit Count
5000
Registration Number
NCT05029583
Locations
🇨🇦

LMC Diabetes & Endocrinology Ltd., Toronto, Ontario, Canada

Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy

Not Applicable
Completed
Conditions
Glucose
Diabetes Mellitus, Type 2
Interventions
Other: Diabetes self-management education
Device: FreeStyle Libre Flash Glucose Monitor
First Posted Date
2020-09-24
Last Posted Date
2023-11-08
Lead Sponsor
LMC Diabetes & Endocrinology Ltd.
Target Recruit Count
116
Registration Number
NCT04562714
Locations
🇨🇦

LMC Brampton, Brampton, Ontario, Canada

🇨🇦

LMC Etobicoke, Etobicoke, Ontario, Canada

🇨🇦

LMC Midtown, Toronto, Ontario, Canada

and more 3 locations

Prevalence and Risk Evaluation of Diabetic Complications of the Foot in A Large Canadian Population

Completed
Conditions
Diabetes Mellitus, Type 1
Diabetes Mellitus, Type 2
Onychauxis
Foot Deformities
Foot Ulcer, Diabetic
Neuropathy, Diabetic
Hyperkeratosis
Onychomycosis
First Posted Date
2020-03-31
Last Posted Date
2021-02-25
Lead Sponsor
LMC Diabetes & Endocrinology Ltd.
Target Recruit Count
5084
Registration Number
NCT04327622
Locations
🇨🇦

LMC Healthcare, Toronto, Canada

Canadian Real-World Outcomes of Omnipod Initiation in People With T1D

Completed
Conditions
Diabetes Mellitus, Type 1
Interventions
Other: MDI
Device: Omnipod
First Posted Date
2020-01-13
Last Posted Date
2020-02-21
Lead Sponsor
LMC Diabetes & Endocrinology Ltd.
Target Recruit Count
286
Registration Number
NCT04226378
Locations
🇨🇦

LMC Healthcare, Toronto, Canada

Real-world Health Outcomes in Canadian Patients Using Semaglutide

Completed
Conditions
Type 2 Diabetes
First Posted Date
2019-11-25
Last Posted Date
2020-02-21
Lead Sponsor
LMC Diabetes & Endocrinology Ltd.
Target Recruit Count
1133
Registration Number
NCT04175665
Locations
🇨🇦

LMC Diabetes & Endocrinology, Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath